?

        當前位置:對照品 > 實驗試劑 > 生化試劑 >
        SB-269970
        ??【編號】:125056

        ??【產(chǎn)品名稱】:SB-269970

        ??【規(guī)格】:10MG

        ??【用途】:

          SB-269970

          Product Name: SB-269970
          CAS號:201038-74-6
          分子式:C18H28N2O3S
          分子量:352.49
          貯存: 儲存溫度-20°C
          可溶性: 25°C: DMSO
          生化和生理學機理:
          Description:
          IC50 Value: 8.3 (pKi for 5-HT7) [1]
          SB269970 is a hydrochloride salt form of SB-269970, which is a 5-HT7 receptor antagonist with pKi of 8.3, exhibits >50-fold selectivity against other receptors.
          in vitro: 5-CT-stimulated adenylyl cyclase activity in guinea-pig hippocampal membranes (pEC(50) of 8.4+/-0.2) was inhibited by SB-269970-A (0.3 microM) with a pK(B) (8.3+/-0.1) in good agreement with its antagonist potency at the human cloned 5-HT(7(a)) receptor and its binding affinity at guinea-pig cortical membranes. 5-HT(7) receptor mRNA was highly expressed in human hypothalamus, amygdala, thalamus, hippocampus and testis [1]. Cortical slices were loaded with [(3)H]-5-HT and release was evoked by electrical stimulation. 5-CT inhibited the evoked release of [(3)H]-5-HT in a concentration-dependent manner. SB-269970 had no significant effect on [(3)H]-5-HT release while the 5-HT(1B) receptor antagonist, SB-224289 significantly potentiated [(3)H]-5-HT release. In addition, SB-269970 was unable to attenuate the 5-CT-induced inhibition of release while SB-224289 produced a rightward shift of the 5-CT response, generating estimated pK(B) values of 7.8 and 7.6 at the guinea-pig and rat terminal 5-HT autoreceptors respectively [2].
          in vivo: Acute administration of SB-269970 (1 mg/kg) or amisulpride (3 mg/kg) ameliorated ketamine-induced cognitive inflexibility and novel object recognition deficit in rats. Both compounds were also effective in attenuating ketamine-evoked disruption of social interactions [3]. Pretreatment with a dose of SB-269970 (0.5 mM) that significantly affects sleep variables antagonized the LP-44 (2.5 mM)-induced suppression of REMS and of the number of REM periods [4].
          Toxicity: N/A
          Clinical trial: N/A
        上一篇:Retaspimycin 下一篇:澳洲茄胺



          ?
          首 頁 | 對照品| 標準品| 標準物質(zhì)| 實驗試劑| 培養(yǎng)基| 菌種購買| 新聞中心| 聯(lián)系我們| 網(wǎng)站地圖

          2011-2018 北京萊耀生物版權所有豫ICP備17046142號

          ? 主站蜘蛛池模板: 布尔津县| 车致| 甘洛县| 乌兰浩特市| 嘉禾县| 元氏县| 神木县| 漠河县| 塔河县| 隆子县| 赤水市| 富裕县| 潼关县| 土默特左旗| 承德县| 泰安市| 屯门区| 南开区| 无锡市| 监利县| 林州市| 浦城县| 门源| 秦皇岛市| 威宁| 东源县| 桐柏县| 芜湖市| 都江堰市| 枝江市| 昌宁县| 深州市| 敦化市| 龙口市| 延庆县| 抚远县| 天长市| 桐庐县| 太谷县| 山阴县| 开阳县|